Nov 8, 2022 06:40AM
Oct 14, 2022 06:18AM
Oct 13, 2022 04:40PM
Oct 13, 2022 04:38PM
Oct 13, 2022 04:37PM
Aug 9, 2022 06:49AM
Aug 9, 2022 06:45AM Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich’s Ataxia
Aug 8, 2022 06:45AM
Jul 11, 2022 06:45AM
Jul 11, 2022 06:45AM
May 26, 2022 06:46AM
May 26, 2022 06:45AM
Feb 25, 2022 05:30PM
Feb 8, 2022 04:06PM SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Reata Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – RETA
Feb 8, 2022 12:00PM
Jan 23, 2022 09:00PM
Jan 17, 2022 09:00PM
Dec 21, 2021 09:00PM
Dec 9, 2021 09:29AM
Dec 9, 2021 08:35AM
Dec 9, 2021 05:52AM Reata Pharma (RETA) Confirms FDA Advisory Committee Voted No on Efficacy of Bardoxolone
Dec 9, 2021 05:50AM
Dec 8, 2021 05:50PM
Dec 8, 2021 05:09PM
Dec 8, 2021 07:38AM
Dec 8, 2021 07:38AM
Nov 8, 2021 06:40AM
Aug 9, 2021 04:01PM Reata Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs
May 24, 2021 04:24AM
May 6, 2021 06:45AM
Apr 26, 2021 04:55PM
Apr 26, 2021 04:54PM
Oct 21, 2020 08:00PM

15,631 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All